He discusses the positioning of JAK inhibitors in the treatment of inflammatory bowel disease, which he presented at the virtual AIBD regional meeting July 25.
Michael Thase, MD, discusses the most important steps for clinicians to take when a first-line antidepressant is not effective and guidelines that can help them decide whether to discontinue an ineffective...